Géraldine Cohuet

2.0k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

Géraldine Cohuet is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Géraldine Cohuet has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Géraldine Cohuet's work include Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Asthma and respiratory diseases (10 papers) and Respiratory and Cough-Related Research (7 papers). Géraldine Cohuet is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Asthma and respiratory diseases (10 papers) and Respiratory and Cough-Related Research (7 papers). Géraldine Cohuet collaborates with scholars based in Italy, United Kingdom and France. Géraldine Cohuet's co-authors include Massimo Corradi, Dave Singh, Jørgen Vestbo, Stefano Vezzoli, Isabella Montagna, Mario Scuri, Alberto Papi, Harry A.J. Struijker-Boudier, Catherine Francisco and Stefano Petruzzelli and has published in prestigious journals such as The Lancet, Endocrinology and Hypertension.

In The Last Decade

Géraldine Cohuet

17 papers receiving 1.3k citations

Hit Papers

Extrafine inhaled triple therapy versus dual bronchodilat... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
    2018 398 citations Alberto Papi, Jørgen Vestbo et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Cohuet Italy 11 1.1k 889 155 63 58 20 1.4k
Ian Naya United Kingdom 23 1.3k 1.2× 1.2k 1.4× 29 0.2× 65 1.0× 3 0.1× 56 1.5k
Warren Pleskow United States 13 461 0.4× 738 0.8× 68 0.4× 40 0.6× 21 0.4× 23 966
Yang Xie China 13 326 0.3× 85 0.1× 22 0.1× 120 1.9× 7 0.1× 38 608
Tahir Muhammad Pakistan 16 157 0.1× 483 0.5× 40 0.3× 195 3.1× 16 0.3× 27 683
Jyotiprakas Chattopadhyay United States 13 79 0.1× 254 0.3× 71 0.5× 56 0.9× 15 0.3× 18 544
Rick Chin Canada 8 135 0.1× 156 0.2× 35 0.2× 356 5.7× 35 0.6× 13 771
Deborah S. Hustead United States 12 76 0.1× 754 0.8× 44 0.3× 172 2.7× 93 1.6× 16 1.1k
Kari Hortos United States 8 209 0.2× 267 0.3× 11 0.1× 61 1.0× 37 0.6× 11 800
Szymon Brzόsko Poland 16 132 0.1× 40 0.0× 92 0.6× 64 1.0× 40 0.7× 53 620

Countries citing papers authored by Géraldine Cohuet

Since Specialization
Citations

This map shows the geographic impact of Géraldine Cohuet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Cohuet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Cohuet more than expected).

Fields of papers citing papers by Géraldine Cohuet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Cohuet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Cohuet. The network helps show where Géraldine Cohuet may publish in the future.

Co-authorship network of co-authors of Géraldine Cohuet

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Cohuet. A scholar is included among the top collaborators of Géraldine Cohuet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Cohuet. Géraldine Cohuet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Papi, Alberto, Jørgen Vestbo, Leonardo M. Fabbri, et al.. (2018). Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. The Lancet. 391(10125). 1076–1084. 398 indexed citations breakdown →
3.
4.
5.
6.
Scuri, Mario, Jørgen Vestbo, Alberto Papi, et al.. (2017). P271 Effect of extrafine single inhaler triple therapy on lung function and use of rescue medication: results from the trinity study. HighWire Press Open Archive. A230.2–A230. 1 indexed citations
7.
Scuri, Mario, Jørgen Vestbo, Alberto Papi, et al.. (2017). P273 Association of incident pneumonia and exacerbations with extrafine triple therapy in one single inhaler in copd patients: a post-hoc analysis from trilogy and trinity studies. HighWire Press Open Archive. A231.2–A232. 1 indexed citations
8.
9.
10.
11.
Vezzoli, Stefano, Paul Jones, Massimo Corradi, et al.. (2015). Patterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbations. OA1969–OA1969. 1 indexed citations
12.
Wedzicha, Jadwiga A., Dave Singh, Jørgen Vestbo, et al.. (2014). Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations. Respiratory Medicine. 108(8). 1153–1162. 86 indexed citations
13.
Agustí, Àlvar, Massimo Corradi, Géraldine Cohuet, et al.. (2013). FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations. European Respiratory Journal. 42(Suppl 57). P762–P762. 1 indexed citations
14.
Wedzicha, Jadwiga A., Paul Jones, Géraldine Cohuet, et al.. (2012). A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations. European Respiratory Journal. 41(1). 12–17. 27 indexed citations
15.
Emmen, Judith M. A., Luc Roumen, Géraldine Cohuet, et al.. (2007). Fadrozole Reverses Cardiac Fibrosis in Spontaneously Hypertensive Heart Failure Rats: Discordant Enantioselectivity Versus Reduction of Plasma Aldosterone. Endocrinology. 149(1). 28–31. 19 indexed citations
16.
Cohuet, Géraldine & Harry A.J. Struijker-Boudier. (2005). Mechanisms of target organ damage caused by hypertension: Therapeutic potential. Pharmacology & Therapeutics. 111(1). 81–98. 120 indexed citations
17.
Boudier, Harry A.J. Struijker, Géraldine Cohuet, & Marcus Baumann. (2004). IMPROVEMENT OF MICROCIRCULATORY DAMAGE. Journal of Hypertension. 22(Suppl. 2). S411–S411.
18.
Boudier, Harry A.J. Struijker, Géraldine Cohuet, Marcus Baumann, & Michel E. Safar. (2003). The heart, macrocirculation and microcirculation in hypertension: a unifying hypothesis. Journal of Hypertension. 21(3). S19–S23. 36 indexed citations
19.
Cohuet, Géraldine, Pascal Challande, Mary Osborne‐Pellegrin, et al.. (2001). Mechanical Strength of the Isolated Carotid Artery in SHR. Hypertension. 38(5). 1167–1171. 32 indexed citations
20.
Lacolley, Patrick, Pascal Challande, Géraldine Cohuet, et al.. (2001). Mechanical properties and structure of carotid arteries in mice lacking desmin. Cardiovascular Research. 51(1). 178–187. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian Naya Breakdown of academic impact, for papers by Warren Pleskow Breakdown of academic impact, for papers by Yang Xie Breakdown of academic impact, for papers by Tahir Muhammad Breakdown of academic impact, for papers by Jyotiprakas Chattopadhyay Breakdown of academic impact, for papers by Rick Chin Breakdown of academic impact, for papers by Deborah S. Hustead Breakdown of academic impact, for papers by Kari Hortos Breakdown of academic impact, for papers by Szymon Brzόsko
Rankless by CCL
2026